Expired patent cut 45 percent off sales of Lundbeck's best-seller

Generic firms were quick to take advantage of the expired patent on Lundbeck's million-dollar drug Onfi.

Photo: /Ritzau Scanpix/Torkil Adsersen

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles